FDA's Center for Biologics Evaluation and Research regulates the following products: allergenic extracts, monoclonal antibodies, biotech derived therapeutics, somatic cell and gene therapy, xenotransplantation, tissues, some devices, whole blood, blood components, blood derivatives, and vaccines.
Chairman Chatter: Embracing the Challenge
Tuesday, 20 Sep 2016 19.09
Women in Pharma Debuts at 2016 ISPE Annual Meeting & Expo
Tuesday, 20 Sep 2016 14.09
You’re All HEROES! Two Powerful Pharma Keynote Messages
Tuesday, 20 Sep 2016 02.09